Robert G. Petit
Chief Tech/Sci/R&D Officer at OS Therapies, Inc.
Profile
Robert G.
Petit's current job(s) include Senior VP & Head-Early Clinical Development at Orionis Biosciences, Inc., Chief Medical & Scientific Officer at OS Therapies, Inc., and Principal at RGP Biotech, LLC.
Dr. Petit's former job(s) include Director-Medical Strategy at Bristol Myers Squibb Co. from 2005 to 2010, Vice President-Clinical Development at MGI PHARMA, Inc. and Aesgen, Inc., and Chief Scientific Officer & Executive VP at Advaxis, Inc. from 2010 to 2019.
He also briefly served as Chief Scientific Officer at CTx Operations, Inc. in 2019.
Dr. Petit obtained his undergraduate degree from Indiana State University and his doctorate degree from The Ohio State University.
Robert G. Petit active positions
| Companies | Position | Start |
|---|---|---|
OS Therapies, Inc.
 OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | Chief Tech/Sci/R&D Officer | 2019-08-31 |
| RGP Biotech, LLC | Corporate Officer/Principal | 2019-05-31 |
Orionis Biosciences, Inc.
 Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | Corporate Officer/Principal | 2022-02-28 |
Former positions of Robert G. Petit
| Companies | Position | End |
|---|---|---|
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Chief Tech/Sci/R&D Officer | 2019-11-30 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2009-12-31 |
Aesgen, Inc.
 Aesgen, Inc. Pharmaceuticals: MajorHealth Technology Aesgen, Inc. develops pharmaceutical products resulting from cancer research collaborations, and specialized delivery of peptides, proteins, and small molecules for critical care. The company is headquartered in Princeton, NJ. | Corporate Officer/Principal | - |
MGI PHARMA, Inc.
 MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Corporate Officer/Principal | - |
| AYALA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2019-06-02 |
Training of Robert G. Petit
| The Ohio State University | Doctorate Degree |
| Indiana State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private companies | 7 |
|---|---|
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Health Technology |
Aesgen, Inc.
Aesgen, Inc. Pharmaceuticals: MajorHealth Technology Aesgen, Inc. develops pharmaceutical products resulting from cancer research collaborations, and specialized delivery of peptides, proteins, and small molecules for critical care. The company is headquartered in Princeton, NJ. | Health Technology |
OS Therapies, Inc.
OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | Commercial Services |
| RGP Biotech, LLC | |
Orionis Biosciences, Inc.
Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | Technology Services |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
- Stock Market
- Insiders
- Robert G. Petit
